The carbon monoxide releasing molecule CORM-2 attenuates Pseudomonas aeruginosa biofilm formation.

PloS One
Thomas S MurrayEmanuela M Bruscia

Abstract

Chronic infections resulting from biofilm formation are difficult to eradicate with current antimicrobial agents and consequently new therapies are needed. This work demonstrates that the carbon monoxide-releasing molecule CORM-2, previously shown to kill planktonic bacteria, also attenuates surface-associated growth of the gram-negative pathogen Pseudomonas aeruginosa by both preventing biofilm maturation and killing bacteria within the established biofilm. CORM-2 treatment has an additive effect when combined with tobramycin, a drug commonly used to treat P. aeruginosa lung infections. CORM-2 inhibited biofilm formation and planktonic growth of the majority of clinical P. aeruginosa isolates tested, for both mucoid and non-mucoid strains. While CORM-2 treatment increased the production of reactive oxygen species by P. aeruginosa biofilms, this increase did not correlate with bacterial death. These data demonstrate that CO-RMs possess potential novel therapeutic properties against a subset of P. aeruginosa biofilm related infections.

References

Feb 9, 2002·Circulation Research·Roberto MotterliniColin J Green
Oct 23, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S K Obaro
Nov 1, 2005·Expert Opinion on Investigational Drugs·Roberto MotterliniRoberta Foresti
Jul 6, 2006·Applied and Environmental Microbiology·Robert M Q ShanksGeorge A O'Toole
Oct 10, 2006·Advances in Microbial Physiology·Huw D WilliamsBen Ryall
May 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lutz WiehlmannBurkhard Tümmler
Aug 24, 2007·The European Respiratory Journal·E BathoornH A M Kerstjens
Oct 10, 2007·Antimicrobial Agents and Chemotherapy·Lígia S NobreLígia M Saraiva
Nov 24, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Martin BilbanLeo E Otterbein
Feb 1, 2008·Pulmonary Pharmacology & Therapeutics·Sophie Moreau-MarquisGeorge A O'Toole
Jun 14, 2008·Free Radical Biology & Medicine·Claude A Piantadosi
Sep 5, 2008·Current Protocols in Microbiology·Judith H MerrittGeorge A O'Toole
Dec 19, 2008·The Journal of Biological Chemistry·Kelly S DavidgeRobert K Poole
Dec 20, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mathieu DesmardJorge Boczkowski
Jan 24, 2009·Trends in Microbiology·Russell D Monds, George A O'Toole
Jan 27, 2009·American Journal of Respiratory Cell and Molecular Biology·Sophie Moreau-MarquisBruce A Stanton
Jun 30, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Shinjiro MizuguchiGediminas Cepinskas
Jul 7, 2010·FEMS Immunology and Medical Microbiology·Mette BurmølleThomas Bjarnsholt
Aug 3, 2010·Nature Reviews. Microbiology·Hans-Curt Flemming, Jost Wingender
Sep 3, 2010·Nature Reviews. Drug Discovery·Roberto Motterlini, Leo E Otterbein
Nov 3, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Jürgen BruggerChristian Wunder
Jun 8, 2011·The Journal of Biological Chemistry·Ana Filipa N TavaresLígia M Saraiva
Aug 2, 2011·Redox Report : Communications in Free Radical Research·Kamil BrzóskaMarcin Kruszewski
Aug 26, 2011·Antioxidants & Redox Signaling·Mathieu DesmardRoberto Motterlini

❮ Previous
Next ❯

Citations

Nov 23, 2012·Medical Gas Research·Roberto MotterliniRoberta Foresti
Jan 30, 2013·Plastic and Reconstructive Surgery·Akhil K SethSeok J Hong
Feb 6, 2013·Biochemical Pharmacology·Tien Van PhanHye-Seon Choi
Dec 21, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Roberto MotterliniRoberta Foresti
Jul 23, 2015·Biomacromolecules·Diep NguyenCyrille Boyer
Jan 1, 2014·Antimicrobial Agents and Chemotherapy·Keiko TarquinioKerry LaPlante
Apr 27, 2016·Antimicrobial Agents and Chemotherapy·Mareike Klinger-StrobelAlexander Schiller
Jun 10, 2015·The Journal of Biological Chemistry·Lauren K WarehamMariana Tinajero-Trejo
Aug 31, 2018·Bioinorganic Chemistry and Applications·Aiten IsmailovaIan S Butler
Sep 9, 2017·Scientific Reports·Caterina Di PietroEmanuela M Bruscia
Jul 11, 2012·FEMS Microbiology Letters·Ana Filipa N TavaresLígia M Saraiva
Oct 23, 2020·Chemical Reviews·Christopher P HopperBinghe Wang
Jun 3, 2021·Antioxidants·Sofia S MendesLígia M Saraiva
Jun 6, 2021·International Journal of Pharmaceutics·Li DingZhengrong Cui
Jul 3, 2021·Pharmaceutics·Alexandra-Cristina Munteanu, Valentina Uivarosi

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00094406

Software Mentioned

Excel
iCORM
VivaView
Minitab

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.